Skip to main content

INTEGRACION DE PERFILES GENOMICOS Y TRANSCRIPTOMICOS PARA LA IDENTIFICACION DE NUEVAS BASES GENETICAS EN LAS INMUNODEFICIENCIAS PRIMARIAS.

PI20/00761

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Execution centre HOSPITAL VALLE DE HEBRON

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

De Novo or inherited, gonosomal mosaicism in hereditary angioedema due to C1 inhibitor deficiency

  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Perurena Prieto, Janire|||0000-0002-3048-1058
  • Viñas-Giménez, Laura|||0000-0003-2913-1154
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Fernández-Álvarez, Paula|||0000-0003-2695-3531
  • Gil-Serrano, Johana|||0000-0002-0673-7391
  • Guilarte, Mar|||0000-0001-7242-9584
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
Hereditary angioedema (HAE) is a rare genetic disease, characterized by transient and self-limiting episodes of subcutaneous or submucosal swelling that spontaneously resolve within two to five days. The most common form of HAE, HAE-C1-INH, is caused by deleterious mutations in the SERPING1 gene, encoding the C1-Inhibitor protein, and its diagnosis is confirmed by decreased C1-INH function. Distinctively from other genetic forms of HAE, up to 15-20% of HAE-C1-INH cases are sporadic caused by de novo mutations. Here, we report a patient with apparently sporadic HAE-C1-INH. The patient had compatible clinical symptoms and a markedly low C1-INH function, and the parents showed normal values of C4 and normal C1-INH function. In the patient, we identified a novel splice site mutation in SERPING1 (c.890-1G.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Somatic reversion in CD137 deficiency correlating with Epstein-Barr virus control and clinical improvement

  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Padrosa Pulido, Joan|||0000-0002-3354-5811
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Perurena-Prieto, Janire
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Cea López, Cristina|||0000-0003-0776-6706
  • Rodriguez-Aliberas, Marta
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Casals, Ferran|||0000-0002-8941-0369
  • Redondo, Sara|||0000-0001-8967-7410
  • Torrent, Montserrat|||0000-0003-1917-1056
  • Alsina Manrique, Laia|||0000-0002-3559-0018
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
Epstein-Barr virus (EBV) is an oncogenic virus ubiquitous in human populations. CD8 T cells play a crucial role in establishing a strong anti-EBV immune response. Among the various inborn errors of immunity (IEI) showing a restricted vulnerability to EBV, TNFRSF9 (CD137, 4-1BB) deficiency was described in 2019 in patients with chronic EBV viremia and EBV-associated lymphoproliferative diseases. We here investigated a patient with a history of chronic EBV infection and CD137 deficiency who had previously undergone transplantation from her HLA-identical brother. We found that the brother was also a homozygous carrier of the same TNFRSF9 variant, explaining the patient's inability to control EBV after transplantation. Remarkably, during a period of spontaneous clinical improvement and EBV control, we detected two somatic variants in the patient, which resulted in the emergence of two independent revertant CD8 T cell clones that accounted for up to 20% of CD8 T cells in peripheral blood. Using single cell RNA sequencing we demonstrated that both revertant clones originated post-transplant from donor-derived cells. We report here the first described case of a somatic reversion phenomenon in TNFRSF9 deficiency, correlating with clinical improvement and paving the way for future gene therapy strategies for this IEI.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Exploring the strengths and limitations of AI-driven variant prioritization versus manual curation in inborn errors of immunity

  • Moushib, Laith Ibrahim
  • Moreno-Ruiz, Nerea
  • Martín-Nalda, Andrea
  • Rivière, Jacques G
  • Urban, Blanca
  • Dieli-Crimi, Romina
  • Perurena-Prieto, Janire
  • Aguiló-Cucurull, Aina
  • Pérez-Estévez, Elena
  • Solanich, Xavier
  • Soler-Palacín, Pere
  • Colobran, Roger
  • Batlle-Masó, Laura
Next-generation sequencing (NGS) has transformed the genetic diagnosis of human diseases, yet many patients remain unsolved due to the complexity of variant interpretation. Manual curation of candidate variants is effective but time-consuming and requires specialized expertise. Artificial intelligence (AI)-driven platforms have emerged as scalable tools for variant prioritization, yet their performance compared with manual curation remains insufficiently evaluated. The aim of this study was to evaluate the performance of AI-driven platforms for variant prioritization in a cohort of patients with inborn errors of immunity (IEI) and to compare their strengths and limitations with manual curation., The author(s) declared that financial support was received for this work and/or its publication. This study was funded by Instituto de Salud Carlos III, grants PI20/00761 and PI23/00161, co-financed by the European Regional Development Fund (ERDF); and by the Jeffrey Modell Foundation. This research is supported by the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN-RITA). LM acknowledges support from The Swedish Board of Student Finance (CSN); NM-R was supported by grant 2021 FI_B_00296 from Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya; and LB-M is supported by an ISCIII postdoctoral fellowship, “Sara Borrell,” CD24/00011, co-financed by the European Union. Some of the samples were analyzed using the AION platform, supported by the AION Research Grant Program (Nostos) awarded to the Translational Immunology Research Group at VHIR. None of the sponsors has been involved in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Exploring the strengths and limitations of AI-driven variant prioritization versus manual curation in inborn errors of immunity

  • Moushib, Laith Ibrahim
  • Moreno-Ruiz, Nerea
  • Urban Vargas, Blanca Angélica
  • Aguiló Cucurull, Aina
  • Martin, Andrea
  • Rivière, Jacques G.
  • Dieli-Crimi Vinuesa, Romina
  • Perurena-Prieto, Janire
  • Soler-Palacin, Pere
  • Colobran, Roger
  • Batlle-Masó, Laura
Artificial intelligence; Genetic diagnosis; Inborn errors of immunity, Inteligencia artificial; Diagnóstico genético; Errores congenitos de la inmunidad, Intel·ligència artificial; Diagnòstic genètic; Errors congènits de la immunitat, Introduction: Next-generation sequencing (NGS) has transformed the genetic diagnosis of human diseases, yet many patients remain unsolved due to the complexity of variant interpretation. Manual curation of candidate variants is effective but time-consuming and requires specialized expertise. Artificial intelligence (AI)-driven platforms have emerged as scalable tools for variant prioritization, yet their performance compared with manual curation remains insufficiently evaluated. The aim of this study was to evaluate the performance of AI-driven platforms for variant prioritization in a cohort of patients with inborn errors of immunity (IEI) and to compare their strengths and limitations with manual curation.Methods: We analyzed 22 unsolved IEI cases that had previously undergone inconclusive NGS studies. Whole-genome sequencing was performed, and variant prioritization was carried out using two AI-driven platforms -AIMARRVEL and AION (Nostos Genomics)- and by manual curation. Selected variants were classified according to clinical relevance (very high, high, medium, or low), integrating both molecular and phenotypic evidence.Results: Across the cohort, AI platforms efficiently prioritized variants with clear pathogenic features, often reaching the same conclusions as manual curation but in a fraction of the time. One patient (5%) received a conclusive diagnosis (FAM111B), and four patients (18%) carried variants of high clinical relevance, including strong disease-causing candidates in CD247 and SH2B3. Additional medium-relevance variants were identified in 36% of cases, although evidence was insufficient for functional validation. Notably, concordance between AIMARRVEL and AION was limited, particularly for variants of uncertain significance (VUS), reflecting differences in algorithmic weighting of variant features versus clinical phenotype. Both platforms also highlighted potentially novel associations in RUNX1 and TRAF7, underscoring their capacity to extend beyond classical IEI genes.Discussion: Our results show that AI-driven tools are powerful for detecting clearly pathogenic variants and can markedly accelerate the diagnostic process. However, their strong reliance on curated databases, limited incorporation of phenotypic data, and challenges in handling VUS may reduce their effectiveness. Enhancing phenotype integration, expanding annotations (including non-coding regions), and incorporating up-to-date literature could improve their performance. Ultimately, AI tools should complement expert curation, with future models evolving toward integrative approaches that better capture the complexity of human disorders., The author(s) declared that financial support was received for this work and/or its publication. This study was funded by Instituto de Salud Carlos III, grants PI20/00761 and PI23/00161, co-financed by the European Regional Development Fund (ERDF); and by the Jeffrey Modell Foundation. This research is supported by the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN-RITA). LM acknowledges support from The Swedish Board of Student Finance (CSN); NM-R was supported by grant 2021 FI_B_00296 from Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya; and LB-M is supported by an ISCIII postdoctoral fellowship, “Sara Borrell,” CD24/00011, co-financed by the European Union. Some of the samples were analyzed using the AION platform, supported by the AION Research Grant Program (Nostos) awarded to the Translational Immunology Research Group at VHIR. None of the sponsors has been involved in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report

  • Franco Jarava, Clara
  • Valenzuela Palafoll, Ma Irene
  • Rivière, Jacques
  • García Prat, Marina
  • Dieli Crimi, Romina
  • Castells Sarret, Neus
  • Batlle Masó, Laura
  • Soler Palacín, Pere
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
Chromosomal rearrangements; Primary immunodeficiencies; Syndromic immunodeficiencies, Reordenacions cromosòmiques; Immunodeficiències primàries; Immunodeficiències sindròmiques, Reordenamientos cromosómicos; Inmunodeficiencias primarias; Inmunodeficiencias sindrómicas, Syndromic immunodeficiencies are a heterogeneous group of inborn errors of immunity that can affect the development of non-immune organs and systems. The genetic basis of these immunodeficiencies is highly diverse, ranging from monogenic defects to large chromosomal aberrations. Antibody deficiency is the most prevalent immunological abnormality in patients with syndromic immunodeficiencies caused by chromosomal rearrangements, and usually manifests as a common variable immunodeficiency (CVID)-like phenotype. Here we describe a patient with a complex phenotype, including neurodevelopmental delay, dysmorphic features, malformations, and CVID (hypogammaglobulinemia, reduced pre-switch and switch memory B cells, and impaired vaccine response). Microarray-based comparative genomic hybridization (aCGH) revealed a 13-Mb deletion on chromosome 4q22.2-q24 involving 53 genes, some of which were related to the developmental manifestations in our patient. Although initially none of the affected genes could be linked to his CVID phenotype, subsequent reanalysis identified NFKB1 haploinsufficiency as the cause. This study underscores the value of periodic reanalysis of unsolved genetic studies performed with high-throughput technologies (eg, next-generation sequencing and aCGH). This is important because of the ongoing incorporation of new data establishing the relationship between genes and diseases. In the present case, NFKB1 had not been associated with human disease at the time aCGH was performed. Eight years later, reanalysis of the genes included in the chromosome 4 deletion enabled us to identify NFKB1 haploinsufficiency as the genetic cause of our patient’s CVID. In the future, other genes included in the deletion may be linked to human disease, allowing us to better define the molecular basis of our patient’s complex clinical phenotype., This study was funded by Instituto de Salud Carlos III, grants PI17/00660 and PI20/00761, cofinanced by the European Regional Development Fund (ERDF). This study was also funded by the Jeffrey Modell Foundation. This work is supported by the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases Network (ERN-RITA).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Detection and evolutionary dynamics of somatic FAS variants in autoimmune lymphoproliferative syndrome, Diagnostic implications

  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Parra-Martínez, Alba|||0000-0002-9564-8912
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Velasco Puyo, Pablo|||0000-0001-7331-9483
  • Antolín, María|||0000-0001-5623-6862
  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
Autoimmune lymphoproliferative syndrome (ALPS) is a rare primary immune disorder characterized by impaired apoptotic homeostasis. The clinical characteristics include lymphoproliferation, autoimmunity (mainly cytopenia), and an increased risk of lymphoma. A distinctive biological feature is accumulation (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene, A Case Report

  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Valenzuela, Irene|||0000-0003-2350-6058
  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Dieli-Crimi, Romina|||0000-0003-3413-5133
  • Castells Sarret, Neus
  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
Syndromic immunodeficiencies are a heterogeneous group of inborn errors of immunity that can affect the development of non-immune organs and systems. The genetic basis of these immunodeficiencies is highly diverse, ranging from monogenic defects to large chromosomal aberrations. Antibody deficiency is the most prevalent immunological abnormality in patients with syndromic immunodeficiencies caused by chromosomal rearrangements, and usually manifests as a common variable immunodeficiency (CVID)-like phenotype. Here we describe a patient with a complex phenotype, including neurodevelopmental delay, dysmorphic features, malformations, and CVID (hypogammaglobulinemia, reduced pre-switch and switch memory B cells, and impaired vaccine response). Microarray-based comparative genomic hybridization (aCGH) revealed a 13-Mb deletion on chromosome 4q22.2-q24 involving 53 genes, some of which were related to the developmental manifestations in our patient. Although initially none of the affected genes could be linked to his CVID phenotype, subsequent reanalysis identified NFKB1 haploinsufficiency as the cause. This study underscores the value of periodic reanalysis of unsolved genetic studies performed with high-throughput technologies (eg, next-generation sequencing and aCGH). This is important because of the ongoing incorporation of new data establishing the relationship between genes and diseases. In the present case, NFKB1 had not been associated with human disease at the time aCGH was performed. Eight years later, reanalysis of the genes included in the chromosome 4 deletion enabled us to identify NFKB1 haploinsufficiency as the genetic cause of our patient's CVID. In the future, other genes included in the deletion may be linked to human disease, allowing us to better define the molecular basis of our patient's complex clinical phenotype.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Case Report, X-Linked SASH3 Deficiency Presenting as a Common Variable Immunodeficiency

  • Labrador Horrillo, Moises|||0000-0003-3222-2380
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Parra-Martínez, Alba|||0000-0002-9564-8912
  • Antolín, María|||0000-0001-5623-6862
  • Salgado-Perandrés, Sandra
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
SASH3 is a lymphoid-specific adaptor protein. In a recent study, SASH3 deficiency was described as a novel X-linked combined immunodeficiency with immune dysregulation, associated with impaired TCR signaling and thymocyte survival in humans. The small number of patients reported to date showed recurrent sinopulmonary, cutaneous and mucosal infections, and autoimmune cytopenia. Here we describe an adult patient previously diagnosed with common variable immunodeficiency (CVID) due to low IgG and IgM levels and recurrent upper tract infections. Two separate, severe viral infections drew our attention and pointed to an underlying T cell defect: severe varicella zoster virus (VZV) infection at the age of 4 years and bilateral pneumonia due type A influenza infection at the age of 38. Genetic testing using an NGS-based custom-targeted gene panel revealed a novel hemizygous loss-of-function variant in the SASH3 gene (c.505C.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report

  • Franco Jarava, Clara
  • Valenzuela Palafoll, Ma Irene
  • Rivière, Jacques
  • García Prat, Marina
  • Dieli Crimi, Romina
  • Castells Sarret, Neus
  • Batlle Masó, Laura
  • Soler Palacín, Pere
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
Chromosomal rearrangements; Primary immunodeficiencies; Syndromic immunodeficiencies, Reordenacions cromosòmiques; Immunodeficiències primàries; Immunodeficiències sindròmiques, Reordenamientos cromosómicos; Inmunodeficiencias primarias; Inmunodeficiencias sindrómicas, Syndromic immunodeficiencies are a heterogeneous group of inborn errors of immunity that can affect the development of non-immune organs and systems. The genetic basis of these immunodeficiencies is highly diverse, ranging from monogenic defects to large chromosomal aberrations. Antibody deficiency is the most prevalent immunological abnormality in patients with syndromic immunodeficiencies caused by chromosomal rearrangements, and usually manifests as a common variable immunodeficiency (CVID)-like phenotype. Here we describe a patient with a complex phenotype, including neurodevelopmental delay, dysmorphic features, malformations, and CVID (hypogammaglobulinemia, reduced pre-switch and switch memory B cells, and impaired vaccine response). Microarray-based comparative genomic hybridization (aCGH) revealed a 13-Mb deletion on chromosome 4q22.2-q24 involving 53 genes, some of which were related to the developmental manifestations in our patient. Although initially none of the affected genes could be linked to his CVID phenotype, subsequent reanalysis identified NFKB1 haploinsufficiency as the cause. This study underscores the value of periodic reanalysis of unsolved genetic studies performed with high-throughput technologies (eg, next-generation sequencing and aCGH). This is important because of the ongoing incorporation of new data establishing the relationship between genes and diseases. In the present case, NFKB1 had not been associated with human disease at the time aCGH was performed. Eight years later, reanalysis of the genes included in the chromosome 4 deletion enabled us to identify NFKB1 haploinsufficiency as the genetic cause of our patient’s CVID. In the future, other genes included in the deletion may be linked to human disease, allowing us to better define the molecular basis of our patient’s complex clinical phenotype., This study was funded by Instituto de Salud Carlos III, grants PI17/00660 and PI20/00761, cofinanced by the European Regional Development Fund (ERDF). This study was also funded by the Jeffrey Modell Foundation. This work is supported by the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases Network (ERN-RITA).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Exploring the strengths and limitations of AI-driven variant prioritization versus manual curation in inborn errors of immunity

  • Moushib, Laith Ibrahim
  • Moreno-Ruiz, Nerea
  • Urban Vargas, Blanca Angélica
  • Aguiló Cucurull, Aina
  • Martin, Andrea
  • Rivière, Jacques G.
  • Dieli-Crimi Vinuesa, Romina
  • Perurena-Prieto, Janire
  • Soler-Palacin, Pere
  • Colobran, Roger
  • Batlle-Masó, Laura
Artificial intelligence; Genetic diagnosis; Inborn errors of immunity, Inteligencia artificial; Diagnóstico genético; Errores congenitos de la inmunidad, Intel·ligència artificial; Diagnòstic genètic; Errors congènits de la immunitat, Introduction: Next-generation sequencing (NGS) has transformed the genetic diagnosis of human diseases, yet many patients remain unsolved due to the complexity of variant interpretation. Manual curation of candidate variants is effective but time-consuming and requires specialized expertise. Artificial intelligence (AI)-driven platforms have emerged as scalable tools for variant prioritization, yet their performance compared with manual curation remains insufficiently evaluated. The aim of this study was to evaluate the performance of AI-driven platforms for variant prioritization in a cohort of patients with inborn errors of immunity (IEI) and to compare their strengths and limitations with manual curation.Methods: We analyzed 22 unsolved IEI cases that had previously undergone inconclusive NGS studies. Whole-genome sequencing was performed, and variant prioritization was carried out using two AI-driven platforms -AIMARRVEL and AION (Nostos Genomics)- and by manual curation. Selected variants were classified according to clinical relevance (very high, high, medium, or low), integrating both molecular and phenotypic evidence.Results: Across the cohort, AI platforms efficiently prioritized variants with clear pathogenic features, often reaching the same conclusions as manual curation but in a fraction of the time. One patient (5%) received a conclusive diagnosis (FAM111B), and four patients (18%) carried variants of high clinical relevance, including strong disease-causing candidates in CD247 and SH2B3. Additional medium-relevance variants were identified in 36% of cases, although evidence was insufficient for functional validation. Notably, concordance between AIMARRVEL and AION was limited, particularly for variants of uncertain significance (VUS), reflecting differences in algorithmic weighting of variant features versus clinical phenotype. Both platforms also highlighted potentially novel associations in RUNX1 and TRAF7, underscoring their capacity to extend beyond classical IEI genes.Discussion: Our results show that AI-driven tools are powerful for detecting clearly pathogenic variants and can markedly accelerate the diagnostic process. However, their strong reliance on curated databases, limited incorporation of phenotypic data, and challenges in handling VUS may reduce their effectiveness. Enhancing phenotype integration, expanding annotations (including non-coding regions), and incorporating up-to-date literature could improve their performance. Ultimately, AI tools should complement expert curation, with future models evolving toward integrative approaches that better capture the complexity of human disorders., The author(s) declared that financial support was received for this work and/or its publication. This study was funded by Instituto de Salud Carlos III, grants PI20/00761 and PI23/00161, co-financed by the European Regional Development Fund (ERDF); and by the Jeffrey Modell Foundation. This research is supported by the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN-RITA). LM acknowledges support from The Swedish Board of Student Finance (CSN); NM-R was supported by grant 2021 FI_B_00296 from Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya; and LB-M is supported by an ISCIII postdoctoral fellowship, “Sara Borrell,” CD24/00011, co-financed by the European Union. Some of the samples were analyzed using the AION platform, supported by the AION Research Grant Program (Nostos) awarded to the Translational Immunology Research Group at VHIR. None of the sponsors has been involved in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.